Background: Neonatal hyperbilirubinemia is a matter of concern as it is increased due to bilirubin induced neurological dysfunction with damage to the auditory system occurring in healthy term infants. Objective: To identify and assess the significance of neonatal hyperbilirubinemia as a risk factor causing hearing loss in term babies. Methods: This observational prospective cohort study was carried out in tertiary care centre, Jaipur, Rajasthan. 62 Full term newborns delivered in our hospital having TSB level >15 mg/dl requiring phototherapy / exchange transfusion were included. These newborns underwent OAE screening before discharge, repeat OAE was done at 3-4 weeks from discharge date and BERA test was done around at 3 months of age. Result: 62 term babies (TSB level >15 mg/dl) were assessed to analyze the effect of neonatal hyperbilirubinemia as a risk factor on the hearing of term babies. significant P value (< 0.05) was found in LSCS delivery, male neonates, term babies weighing< 2500gm and SGA Neonates & S.bilirubin was not a significant risk (p value >0.05) factor for 1stOAE Test (at discharge). The correlation of Repeat OAE test vs. BERA showed that Repeat OAE test had a sensitivity of 90%, specificity 100% and accuracy 90.3%. Conclusion: This study was an attempt to show the importance of developing a hearing screen with OAE that when repeated appropriately and when required combined with BERA for cases that fail serves as an effective screening test.